« A reduced fixed dose of Tocilizumab 200 mg compared to 400 mg in patients with severe COVID-19 disease », OH&RM, vol. 4, nᵒ 4, p. 19–26, sept. 2023, doi: 10.38045/ohrm.2023.4.02.